SR One Capital Management, LP
Redwood City, CA · CIK 1910264 · 13F filing filed 2026-05-14
SEC-registered investment adviser since 2020 · limited partnership
- Assets managed$2.4bn
- Staff28 · 15 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds19 · $2.4bn gross assets
- Websitesrone.com
- Form ADV · 2026-03-31SEC adviser record
- Kindprivate equity
- Others nearbyRedwood City, CA, London
As an employer
- Offices in2 countries
- Private fundsprivate equity 19
Where they work
Offices
From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.
| City | People |
|---|---|
| Redwood City, CA (main office)United States | about 10 |
| LondonUnited Kingdom | 5 |
Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.
$915.4m
reported value
+29.6% vs Q4 2025
14positions
96.5%in top 10
1 new
0 added
0 reduced
0 sold out
vs Q4 2025
Holdings, Q1 2026
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| ARCELLX INC ACLX | $269.4m29.43% | Unchanged |
| VERADERMICS INC MANE | $151.7m16.57% | New |
| ZENAS BIOPHARMA INC ZBIO | $98.5m10.76% | Unchanged |
| CRISPR THERAPEUTICS AG CRSP | $97.0m10.59% | Unchanged |
| DESIGN THERAPEUTICS INC DSGN | $69.4m7.59% | Unchanged |
| ORIC PHARMACEUTICALS INC ORIC | $58.5m6.39% | Unchanged |
| ALUMIS INC ALMS | $43.2m4.72% | Unchanged |
| MINERALYS THERAPEUTICS INC MLYS | $42.4m4.63% | Unchanged |
| ARS PHARMACEUTICALS INC SPRY | $32.2m3.52% | Unchanged |
| ORUKA THERAPEUTICS INC ORKA | $21.1m2.31% | Unchanged |
| OCULIS HOLDING AG OCS | $17.0m1.86% | Unchanged |
| NKARTA INC NKTX | $7.0m0.77% | Unchanged |
| ENGENE HOLDINGS INC COM | $5.1m0.56% | Unchanged |
| ULTRAGENYX PHARMACEUTICAL IN RARE | $2.9m0.32% | Unchanged |